In another signal of the appetite among investors for companies applying artificial intelligence to drug discovery, Pathos AI has gathered an impressive $365 million in fourth-round financing as it ...

Results from St. Louis-based Ascension’s fiscal third quarter of 2026 show a system that, after nearly three years of financial turnaround, is starting to turn the tide. Ascension reported a $64 ...

Today, Melania and I join with many Christians in the United States and all around the world who are celebrating the memorial feast day of the Ascension of Jesus into Heaven. Forty days ago, the world ...

Since 1987, players could explore ever-new dungeons in “NetHack”. Almost 40 years later, there is now a major update for the enormously extensive title. One of the oldest still actively developed ...

The latest version 5.0.0 of NetHack, a classic roguelike game from 1987 where players explore dungeons using characters represented by '@', has been released. It reportedly includes over 3100 fixes ...

Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...

London-listed PRTech firm Pathos Communications has created PathosMind, a proprietary AI platform built exclusively for use by its employees and partners. The platform is designed to identify stories ...

St. Louis-based Ascension this week announced its new Clinical Innovation Institute, designed as a center of excellence devoted to vetting emerging technologies and harnessing that innovation for ...

Ascension CEO Joseph Impicciche will retire at the end of the year and be succeeded by the Catholic health giant’s current president, Eduardo Conrado. The handoff, announced Tuesday, was described as ...

Over the last 16 months, St. Louis-based Ascension has sold or consolidated about 35 hospitals across the country as it revamps its hospital portfolio, operating model and overall financial ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI, the biotech drug developer spun out of Tempus ...